DB17460InvestigationalCell transplant therapies
CD8+ enriched young tumor infiltrating lymphocytes: Overview.
- Also known as
- CD8 enriched young TIL
What you can answer from here — as of April 23, 2025
Which companies are running trials of CD8+ enriched young tumor infiltrating lymphocytes, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account